OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:35123
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency, sometimes called SCHAD deficiency or HAD deficiency, is a rare inherited metabolic disorder. It is now more commonly referred to as 3-hydroxyacyl-CoA dehydrogenase deficiency or, in its most recognized form, as a cause of congenital hyperinsulinism. The condition affects the body's ability to break down certain fats for energy. Specifically, an enzyme called short chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD), produced by the HADH gene, does not work properly. This enzyme plays an important role in a process called fatty acid oxidation, which helps the body convert fats into usable energy, especially when food intake is low. Because this enzyme is also involved in regulating insulin release from the pancreas, people with SCHAD deficiency often experience dangerously low blood sugar levels (hypoglycemia) caused by too much insulin being released. This is known as hyperinsulinemic hypoglycemia. Symptoms can appear in newborns or infants and may include seizures, poor feeding, and unusual sleepiness. Without prompt diagnosis and treatment, repeated low blood sugar episodes can cause serious brain injury. Treatment focuses on preventing hypoglycemia through diet, medication, and careful monitoring. The word 'obsolete' in the Orphanet classification reflects updates in how this condition is named and categorized, but the disease itself is real and still recognized by specialists.

Also known as:

Key symptoms:

Very low blood sugar (hypoglycemia)Too much insulin in the blood (hyperinsulinism)Seizures or convulsionsPoor feeding or difficulty eatingUnusual sleepiness or hard to wake upPale or sweaty skinIrritability or fussiness in infantsLiver problems (elevated liver enzymes)Elevated levels of certain fatty acid breakdown products in blood or urineDevelopmental delays if hypoglycemia is not well controlled

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency community →

No specialists are currently listed for OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiencyForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Start the conversation →

Latest news about OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency

No recent news articles for OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How often does my child need to eat, and what should I do if they refuse to eat or are sick?,Is diazoxide the right medication for my child, and what side effects should I watch for?,What are the signs of low blood sugar, and how should I treat it at home?,Does my child need a continuous glucose monitor, and how often should blood sugar be checked?,Are there any dietary restrictions or specific foods that help manage this condition?,What is the long-term outlook for my child's development and health?,Should other family members be tested for this condition?

Common questions about OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency

What is OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency?

Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency, sometimes called SCHAD deficiency or HAD deficiency, is a rare inherited metabolic disorder. It is now more commonly referred to as 3-hydroxyacyl-CoA dehydrogenase deficiency or, in its most recognized form, as a cause of congenital hyperinsulinism. The condition affects the body's ability to break down certain fats for energy. Specifically, an enzyme called short chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD), produced by the HADH gene, does not work properly. This enzyme plays an important role in a process called fatty acid oxidation, w

How is OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency inherited?

OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency typically begin?

Typical onset of OBSOLETE: Short chain 3-hydroxyacyl-CoA dehydrogenase deficiency is neonatal. Age of onset can vary across affected individuals.